Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.
Lixin Qiao, Sungwoon Choi, April Case, Thomas G Gainer, Kathleen Seyb, Marcie A Glicksman, Donald C Lo, Ross L Stein, Gregory D Cuny
Index: Bioorg. Med. Chem. Lett. 19 , 6122, (2009)
Full Text: HTML
Abstract
A structure-activity relationship study for a 2-chloroanilide derivative of pyrazolo[1,5-a]pyridine revealed that increased EphB3 kinase inhibitory activity could be accomplished by retaining the 2-chloroanilide and introducing a phenyl or small electron donating substituents to the 5-position of the pyrazolo[1,5-a]pyridine. In addition, replacement of the pyrazolo[1,5-a]pyridine with imidazo[1,2-a]pyridine was well tolerated and resulted in enhanced mouse liver microsome stability. The structure-activity relationship for EphB3 inhibition of both heterocyclic series was similar. Kinase inhibitory activity was also demonstrated for representative analogs in cell culture. An analog (32, LDN-211904) was also profiled for inhibitory activity against a panel of 288 kinases and found to be quite selective for tyrosine kinases. Overall, these studies provide useful molecular probes for examining the in vitro, cellular and potentially in vivo kinase-dependent function of EphB3 receptor.
Related Compounds
Related Articles:
A simple Cu-catalyzed coupling approach to substituted 3-pyridinol and 5-pyrimidinol antioxidants.
2008-12-05
[J. Org. Chem. 73(23) , 9326-33, (2008)]
FT-Raman and FT-IR spectra, vibrational assignments and density functional studies of 5-bromo-2-nitropyridine. Sundaraganesan N, et al.
[Spectrochim. Acta A 61(13) , 2995-3001, (2005)]
Synthesis of fluorine-18-labelled 5-and 6-fluoro-2-pyridinamine. Abrahim A, et al.
[J. Labelled Comp. Radiopharm. 49(4) , 345-356, (2006)]
Structure-based design and synthesis of the first weak non-phosphate inhibitors for IspF, an enzyme in the non-mevalonate pathway of isoprenoid biosynthesis. Baumgartner C, et al.
[Helv. Chim. Acta 90(6) , 1043-1068, (2007)]